Insulin producer Indar sees 85.7% fall in net profit in Q3 2017
Private joint-stock company Indar insulin producer (Kyiv) saw its net profit decline by 85.7% in July-September 2017 year-over-year, to UAH 4.328 million from UAH 30.68 million. According to a company report, net revenue fell by 30%, to UAH 142.461 million. Gross profit declined by 36.4% year-over-year, to UAH 66.545 million. As reported, in 2016 Indar … Read more